Invention Application
- Patent Title: APEX AS A MARKER FOR LUNG CANCER
- Patent Title (中): APEX作为肺癌标志物
-
Application No.: US12556879Application Date: 2009-09-10
-
Publication No.: US20110097756A1Publication Date: 2011-04-28
- Inventor: Marie-Luise Hagmann , Johann Karl , Julia Kloeckner , Markus Roessler , Michael Tacke , Michael Thierolf
- Applicant: Marie-Luise Hagmann , Johann Karl , Julia Kloeckner , Markus Roessler , Michael Tacke , Michael Thierolf
- Priority: EP07006079.3 20070323
- Main IPC: C12Q1/44
- IPC: C12Q1/44
Abstract:
The present invention relates to the assessment of lung cancer. It discloses the use of protein AP endonuclease (APEX) in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample derived from an individual by measuring APEX in the sample. Measurement of APEX can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
Information query
